
Innobic (Asia), the life science arm of national oil and gas conglomerate PTT Plc, expects to earn first-year profit of more than 100 million baht, driven in particular by its medicine business.
Buranin Rattanasombat, PTT's senior executive vice-president and chairman of Innobic (Asia), said the returns are based on the 2022 performance of businesses, following investments of more than 10 billion baht that the company has made in recent years.